“…In GMS the onset of nephrotic syndrome occurs early in life (0-34 months, median 3 months), with no response to treatment and progressive deterioration of renal function [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]. The kidney biopsy findings described in GMS range from minimal change disease (MCD), mesangioproliferative glomerulonephritis, focal segmental glomerulosclerosis (FSGS) to diffuse mesangial sclerosis (DMS) [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]. The neurological manifestations include microcephaly, psychomotor retardation, and structural central nervous system anomalies that on gross anatomy include abnormal sulci and gyri, pachygyria, cortical atrophy, and cerebellar dysgenesis/hypoplasia, and on histopathology migrational anomalies of the neurons (neuronal heterotopias, abnormal or failed lamination of cortex) [1,2,3,4,5,6,7,8,9,10,11,12,13,…”